The Asia-Pacific region (APAC) is the new life sciences frontier. It already accounts for a major share of the global market size and is producing remarkable growth in multiple life sciences sectors. The region presents an immense, but also immensely challenging, commercial opportunity for future-ready biopharma, medical device and healthcare companies.
In this Special Report, L.E.K. Consulting’s Life Sciences practice explores APAC market entry opportunities and asks: Which markets should be prioritized? What are the optimal market entry models? How can companies optimize their marketing promotion strategies and organizational structure? And what lessons can be learned from the pioneers in APAC life sciences?
Successful APAC market entry is within reach. Small- to medium-sized life science companies need only to start thinking beyond the U.S./EU axis, then learn how to best leverage local resources and partners to drive success in the region.
Biotech and Pharmaceuticals
Five Essential Factors for a Successful Biopharma Product Launch
Life Sciences & Pharma
Clinical Trial Challenges: Patient Recruitment and Diversity